Abeona Therapeutics Inc.
ABEO
$5.28
$0.418.42%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -9.35% | 9.48% | 16.42% | 5.09% | 3.33% |
| Gross Profit | 10.58% | -8.19% | -30.79% | -17.69% | -16.44% |
| SG&A Expenses | 92.58% | 59.26% | 46.92% | 57.08% | 48.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.63% | 32.08% | 28.92% | 24.20% | 20.19% |
| Operating Income | -36.97% | -31.37% | -37.86% | -33.22% | -29.31% |
| Income Before Tax | 216.38% | 238.32% | 42.36% | -17.62% | -58.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 215.93% | 208.83% | 42.36% | -17.62% | -58.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 215.93% | 208.83% | 42.36% | -17.62% | -58.84% |
| EBIT | -36.97% | -31.37% | -37.86% | -33.22% | -29.31% |
| EBITDA | -37.75% | -32.30% | -39.66% | -35.49% | -32.26% |
| EPS Basic | 168.76% | 148.24% | 72.63% | 30.73% | 9.11% |
| Normalized Basic EPS | 40.24% | 23.73% | 73.10% | 32.23% | 8.36% |
| EPS Diluted | 143.55% | 125.31% | 58.64% | 13.40% | -9.03% |
| Normalized Diluted EPS | 46.24% | 30.48% | 71.86% | 30.70% | 6.70% |
| Average Basic Shares Outstanding | 45.45% | 68.96% | 94.68% | 92.11% | 92.93% |
| Average Diluted Shares Outstanding | 44.00% | 65.21% | 106.38% | 105.24% | 108.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |